ChartRow logo
RVMD
Revolution Medicines Inc.Stock · Health Care
$197.81+$0.51 (+0.26%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

RVMD financial statements

The full income statement, balance sheet, and cash-flow statement for Revolution Medicines Inc. (RVMD), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 167.0M2024-09 168.2M2024-12 185.9M2025-03 186.3M2025-06 186.9M2025-09 193.3M2025-12 198.2M2026-03 212.6M2026-06 214.3M+28.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
0.00
0.00
YoY-100.0%
11.6M
YoY-67.3%
35.4M
YoY+20.4%
29.4M
YoY-31.6%
1.18B
YoY+71.5%
690M
YoY+38.2%
499M
YoY+69.8%
294M
YoY+35.1%
217M
YoY+41.5%
Operating income
-1.18B
YoY-71.5%
-690M
YoY-41.5%
-487M
YoY-88.6%
-258M
YoY-37.4%
-188M
YoY-69.8%
Interest expense
24.2M
0.00
0.00
0.00
YoY-100.0%
12.0K
YoY-83.1%
Interest & investment income
90.7M
YoY+4.4%
86.9M
YoY+83.0%
47.5M
YoY+418.7%
9.15M
YoY+885.4%
929K
YoY-58.5%
Other non-operating income
51.1M
YoY-42.4%
88.7M
YoY+87.5%
47.3M
YoY+416.6%
9.15M
YoY+898.3%
917K
YoY-57.7%
Pre-tax income
-1.13B
YoY-88.3%
-601M
YoY-36.6%
-440M
YoY-76.6%
-249M
YoY-33.2%
-187M
YoY-72.4%
Income tax
0.00
YoY+100.0%
-753K
YoY+78.6%
-3.52M
YoY-739.0%
-420K
0.00
YoY+100.0%
-1.13B
YoY-88.5%
-600M
YoY-37.5%
-436M
YoY-75.5%
-249M
YoY-32.9%
-187M
YoY-73.0%
-$5.95
YoY-66.2%
-$3.58
YoY+7.3%
-$3.86
YoY-25.3%
-$3.08
YoY-19.8%
-$2.57
YoY-27.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
2.08B
YoY-10.9%
2.33B
YoY+23.9%
1.88B
YoY+184.7%
660M
YoY+11.9%
590M
YoY+29.9%
2.35B
YoY-8.0%
2.56B
YoY+24.1%
2.06B
YoY+153.9%
812M
YoY+10.0%
738M
YoY+30.1%
290M
YoY+77.2%
164M
YoY+13.9%
144M
YoY+132.1%
62.0M
YoY+2.7%
60.4M
YoY+27.9%
723M
YoY+146.7%
293M
YoY+24.5%
236M
YoY+85.8%
127M
YoY-6.4%
135M
YoY+46.0%
1.63B
YoY-28.0%
2.27B
YoY+24.0%
1.83B
YoY+166.5%
685M
YoY+13.7%
603M
YoY+26.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-898M
YoY-61.0%
-557M
YoY-59.0%
-351M
YoY-56.2%
-224M
YoY-52.5%
-147M
YoY-47.1%
118M
YoY+121.3%
-554M
YoY-61.8%
-343M
YoY-1320.6%
-24.1M
YoY+83.0%
-142M
YoY+39.3%
622M
YoY-35.2%
959M
YoY-21.9%
1.23B
YoY+307.8%
301M
YoY+2.5%
294M
YoY-30.4%
Net change in cash
-158M
YoY-3.8%
-152M
YoY-128.4%
536M
YoY+913.0%
52.9M
YoY+983.9%
4.88M
YoY-94.5%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
15.8B
YoY+94.1%
8.13B
YoY+158.8%
3.14B
YoY+48.6%
2.11B
YoY+13.3%
1.87B
YoY-35.7%
P/S
120.1×
YoY+67.5%
71.7×
YoY+12.8%
63.5×
YoY-6.0%
P/B
9.7×
YoY+169.5%
3.6×
YoY-4.3%
3.8×
YoY+20.9%
3.1×
YoY+0.2%
3.1×
YoY-49.4%
Source filing10-K10-K10-K10-K10-K

About this data

Source: RVMD's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RVMD filings on SEC EDGAR → Not investment advice.